Reza Haque

469 total citations
11 papers, 346 citations indexed

About

Reza Haque is a scholar working on Ophthalmology, Public Health, Environmental and Occupational Health and Pharmacology. According to data from OpenAlex, Reza Haque has authored 11 papers receiving a total of 346 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Ophthalmology, 5 papers in Public Health, Environmental and Occupational Health and 2 papers in Pharmacology. Recurrent topics in Reza Haque's work include Ocular Infections and Treatments (5 papers), Ocular Surface and Contact Lens (5 papers) and Glaucoma and retinal disorders (4 papers). Reza Haque is often cited by papers focused on Ocular Infections and Treatments (5 papers), Ocular Surface and Contact Lens (5 papers) and Glaucoma and retinal disorders (4 papers). Reza Haque collaborates with scholars based in United States, India and Switzerland. Reza Haque's co-authors include Victor L. Perez, Stephen C. Pflugfelder, Steven Zhang, Amir Shojaei, Richard C. Zink, Wenlei Liu, Jay S. Pepose, Francis S. Mah, Regis P. Kowalski and Gail Torkildsen and has published in prestigious journals such as BMJ, American Journal of Ophthalmology and Drug Safety.

In The Last Decade

Reza Haque

11 papers receiving 334 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Reza Haque United States 7 228 169 101 78 71 11 346
Chika Shigeyasu Japan 14 279 1.2× 216 1.3× 147 1.5× 76 1.0× 48 0.7× 30 399
Murray Friedberg United States 6 266 1.2× 139 0.8× 140 1.4× 70 0.9× 43 0.6× 7 347
Srihari Narayanan United States 12 501 2.2× 205 1.2× 274 2.7× 106 1.4× 88 1.2× 18 625
Tammy A. Schwalb United States 5 478 2.1× 161 1.0× 196 1.9× 122 1.6× 101 1.4× 7 518
James A. Gow United States 13 154 0.7× 291 1.7× 60 0.6× 118 1.5× 42 0.6× 37 464
Seika Shimazaki-Den Japan 12 310 1.4× 252 1.5× 246 2.4× 55 0.7× 41 0.6× 15 421
Tulio Batista Abud United States 7 245 1.1× 147 0.9× 252 2.5× 28 0.4× 19 0.3× 10 351
I A Mackie United Kingdom 11 366 1.6× 188 1.1× 162 1.6× 44 0.6× 53 0.7× 19 436
Robert Ralph United States 5 284 1.2× 127 0.8× 207 2.0× 21 0.3× 32 0.5× 10 364
Helene Lam United States 5 420 1.8× 182 1.1× 224 2.2× 96 1.2× 99 1.4× 6 492

Countries citing papers authored by Reza Haque

Since Specialization
Citations

This map shows the geographic impact of Reza Haque's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reza Haque with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reza Haque more than expected).

Fields of papers citing papers by Reza Haque

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Reza Haque. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reza Haque. The network helps show where Reza Haque may publish in the future.

Co-authorship network of co-authors of Reza Haque

This figure shows the co-authorship network connecting the top 25 collaborators of Reza Haque. A scholar is included among the top collaborators of Reza Haque based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Reza Haque. Reza Haque is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Pepose, Jay S., et al.. (2019). <p>A randomized controlled trial of povidone-iodine/dexamethasone ophthalmic suspension for acute viral conjunctivitis</p>. Clinical ophthalmology. Volume 13. 535–544. 19 indexed citations
2.
Pepose, Jay S., et al.. (2018). Randomized, Controlled, Phase 2 Trial of Povidone-Iodine/Dexamethasone Ophthalmic Suspension for Treatment of Adenoviral Conjunctivitis. American Journal of Ophthalmology. 194. 7–15. 42 indexed citations
3.
Haque, Reza, et al.. (2017). Efficacy and safety of dexamethasone/povidone-iodine ophthalmic suspension in adenoviral conjunctivitis. 58(8). 3602–3602. 1 indexed citations
4.
Perez, Victor L., Stephen C. Pflugfelder, Steven Zhang, Amir Shojaei, & Reza Haque. (2016). Lifitegrast, a Novel Integrin Antagonist for Treatment of Dry Eye Disease. The Ocular Surface. 14(2). 207–215. 150 indexed citations
5.
Rasmussen, Carol A., Paul L. Kaufman, Robert Ritch, et al.. (2014). Latrunculin B Reduces Intraocular Pressure in Human Ocular Hypertension and Primary Open-Angle Glaucoma. Translational Vision Science & Technology. 3(5). 1–1. 25 indexed citations
6.
Swale, V.J., et al.. (2013). Erythroderma in the emergency department. BMJ. 346(jun13 4). f3613–f3613. 1 indexed citations
7.
Nichols, Jason J., et al.. (2011). Safety and Efficacy of Topical Azithromycin Ophthalmic Solution 1.0% in the Treatment of Contact Lens–Related Dry Eye. Eye & Contact Lens Science & Clinical Practice. 38(2). 73–79. 28 indexed citations
8.
Haque, Reza, Gail Torkildsen, K. Brubaker, et al.. (2010). Multicenter Open-Label Study Evaluating the Efficacy of Azithromycin Ophthalmic Solution 1% on the Signs and Symptoms of Subjects With Blepharitis. Cornea. 29(8). 871–877. 69 indexed citations
9.
Ritch, Robert, Richard C. Zink, Michael A. Lemp, et al.. (2010). Latrunculin B (ins115644) Reduces Intraocular Pressure (iop) in Ocular Hypertension (oht) and Primary Open Angle Glaucoma (poag). 51(13). 6432–6432. 3 indexed citations
10.
Torkildsen, Gail, et al.. (2009). Efficacy of Topical Azithromycin Ophthalmic Solution 1.0% in the Treatment of Chronic Blepharitis Patients. 50(13). 2661–2661. 2 indexed citations
11.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chika Shigeyasu Breakdown of academic impact, for papers by Murray Friedberg Breakdown of academic impact, for papers by Srihari Narayanan Breakdown of academic impact, for papers by Tammy A. Schwalb Breakdown of academic impact, for papers by James A. Gow Breakdown of academic impact, for papers by Seika Shimazaki-Den Breakdown of academic impact, for papers by Tulio Batista Abud Breakdown of academic impact, for papers by I A Mackie Breakdown of academic impact, for papers by Robert Ralph Breakdown of academic impact, for papers by Helene Lam
Rankless by CCL
2026